THIRD ANNUAL CONFERENCE OF THE FERTILITY PRESERVATION SOCIETY (INDIA), BENGALURU – INDIA
The event ‘FERTIPROTECT 2016’, the Third Annual Conference organized of the Fertility Preservation Society (India) will be held on the 27th & 28th of August, 2016.
We live in an era where the incidence of cancer is on the rise in young people, Women are attempting their first pregnancy at an older age and many environmental factors are contributing to increasing infertility. We also recognize that certain autoimmune disorders and genetic conditions lead to a reduction in ovarian reserve prematurely. Preservation of fertility has thus become a very important objective in Reproductive medicine and Oncology.
Oncofertility requires a clear decision-making process, adequate counseling about the future fertility, different methods of fertility preservation as well as an understanding of oncological and obstetrical risks. Appropriate selection for fertility preservation and management of cancer, and careful follow-up within a multidisciplinary setting is very important.
At “Fertiprotect 2016” the effects of cancer treatment on fertility and sexual function will be highlighted. There will be a detailed deliberation on technologies in fertility preservation in both pre-pubertal children and adults.
This educational conference benefits not only oncologists and ART specialists, but general gynaecological practitioners as well. Gynaecologists are trusted family doctors and are involved in all major decision making within the family. 'Fertiprotect 2016' reaches out to all those wishing to gain knowledge in the exciting field of fertility preservation advancements.
This meeting will provide a platform for oncologist, ART specialist and gynecologist to exchange information and treatment strategies.
This academic meeting will have lectures, symposiums, panel discussions and debates.
Invited International Speakers:
TERESA K WOODRUFF – USA
The Chief of the Division of Fertility Preservation at the Feinberg School of Medicine. A reproductive endocrinologist, she has spent the better part of her research career focusing on female reproductive health and infertility.
One of the pioneers in the field of fertility preservation, she coined the term 'Oncofertility' and is the founder of the Oncofertility Consortium.
D MEIROW – ISRAEL
Laboratory Head, Tel Aviv University. Dept of Obstetrics and Gynecology. Israel
Elected President of the International Society for Fertility Preservation (ISFP)
A pioneer in the field of fertility preservation and has done extensive research on fertility preservation in cancer patients. He is the first to investigate the effects of chemotherapy on gonads and how to prevent side effects of chemotherapy on the gonads.
JENNIFER LEVINE – USA
Co-director of the Center for Comprehensive Wellness at New York-Presbyterian/Morgan Stanley Children's Hospital, which has a focus on survivorship. She is a board-certified pediatric hematologist-oncologist with a goal of curing cancer, one child at a time. In addition to supportive care, she specializes in the treatment of children and adolescents with leukemia. She has a special interest in the effects of chemotherapy on fertility, with a research focus on identifying patients most at risk of impaired fertility so they can be offered fertility-preserving approaches.
ETHIRAJ BALAJI – SINGAPORE
Head & Chief Embryologist, Thomson Fertility Centre. He was Adjunct Lecturer (Duke-NUS Graduate Medical School (2009-2011). He was also an invited member of Pro-term National Oversight committee on Human Animal combination Research, MOH, Singapore. He is also a member in Editorial Committee of three International Journals
His most recent achievement was the world’s first live birth from frozen-thawed embryos obtained after maturation (in the lab) IVM and ICSI of oocytes recovered from surgically removed Oophorectomised cancerous ovary.
W BUDI – INDONESIA
Coordinator for Research & Development for the Faculty of Medicine at Universitas Indonesia and also a Supporting Manager for Yasmin IVF Clinic in Jakarta, Indonesia. He actively publishes on ART researches, especially in the areas of AMH, individualized controlled ovarian stimulation (iCOS), ovarian tissue vitrification and embryo metabolomics. President of IA-IVF for 2016-2020 and a member of the Merck Serono Asia Pacific advisory board.
Eminent Oncologists, ART Specialist and Gynaecologists of India.
Check the Program Schedule here.
Please note the deadline for Registration and Medical Council Credit points is 20th of Aug, 2016.